Ultromics Company
They are building world-class diagnostic aids to help cardiologists вАФ powered by artificial intelligence. To date, they have developed the worldвАЩs most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.
Investors
%20.png)
Founded Date:
2017-01-01
Last Funding Type:
Series B
Headquarters:
Oxford, Oxfordshire, United Kingdom
Investors Number:
13
Technology:
HealthCare Administration
Employee Number:
11-50
Industry:
Imaging
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-08-16
Funding Status:
Early Stage Venture
Total Funding:
58824943